Cartesian Therapeutics, Inc. (RNAC)

Typically moves ±6.13% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED

Cartesian Therapeutics, Inc. (RNAC) has reported earnings 18 times since May 13, 2021. The stock moves an average of ±6.13% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +31.68% (Mar 09, 2026) and its largest decline was -9.43% (Aug 08, 2024). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings reactions

How RNAC moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.13%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Apr 30, 2026	☀ PRE	-3.86%	open_in_new
Mar 09, 2026	☀ PRE	+31.68%	open_in_new
Nov 06, 2025	☀ PRE	-1.56%	open_in_new
Aug 07, 2025	☀ PRE	-6.56%	open_in_new
May 08, 2025	☀ PRE	+2.66%	open_in_new
Mar 13, 2025	☀ PRE	-4.98%	open_in_new
Nov 07, 2024	☀ PRE	-0.38%	open_in_new
Aug 08, 2024	☀ PRE	-9.43%	open_in_new
May 08, 2024	☀ PRE	+0.19%	open_in_new
Mar 07, 2024	☀ PRE	-8%	open_in_new
Aug 17, 2023	☀ PRE	+2.75%	open_in_new
Nov 03, 2022	☀ PRE	+3.68%	open_in_new
Aug 04, 2022	☀ PRE	+13.94%	open_in_new
May 05, 2022	☀ PRE	+1.12%	open_in_new
Mar 10, 2022	☀ PRE	+0%	open_in_new
Nov 09, 2021	☀ PRE	-2.78%	open_in_new
Aug 12, 2021	☀ PRE	+14.4%	open_in_new
May 13, 2021	☀ PRE	-2.33%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.13%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 12 →

Funds holding

$6049350

Total value held

Buying

8 added · 4 reduced

Blackrock, Inc.

$3684515 -1.74%

State Street Corp

$1232073 +0.69%

Northern Trust Corp

$565750 +5.72%

Goldman Sachs Group Inc

$190201 NEW BUY

Bank Of New York Mellon Corp

$160509 +3.40%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260722	open_in_new SEC.gov
8-K	20260617	open_in_new SEC.gov
144	20260609	open_in_new SEC.gov
8-K	20260609	open_in_new SEC.gov
144	20260602	open_in_new SEC.gov
8-K	20260526	open_in_new SEC.gov
SCHEDULE 13G/A	20260506	open_in_new SEC.gov
10-Q	20260430	open_in_new SEC.gov
8-K	20260430	open_in_new SEC.gov
S-8	20260430	open_in_new SEC.gov

Frequently asked about RNAC earnings

When does Cartesian Therapeutics, Inc. report earnings next? expand_more

Cartesian Therapeutics, Inc. (RNAC)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RNAC stock move after earnings? expand_more

Over 18 reports, RNAC has moved an average of ±6.13% the session after earnings, closing higher 50.0% of the time.

What was RNAC's biggest post-earnings move? expand_more

RNAC's largest post-earnings gain on record was +31.68% on Mar 09, 2026, and its largest decline was -9.43% on Aug 08, 2024.

Where can I find Cartesian Therapeutics, Inc.'s SEC filings? expand_more

All of Cartesian Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.